Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes - Test2 - elhamkhani - TriplyDB

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

http://www.wikidata.org/entity/Q29614548

about

Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole Modulation of de novo purine biosynthesis leads to activation of AMPK and results in improved glucose handling and insulin sensitivity Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria Insulin and insulin resistance.Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.Genes and pathophysiology of type 2 diabetes: more than just the Randle cycle all over again MicroRNA-210: a unique and pleiotropic hypoxamir Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial Epigenetics: a molecular link between environmental factors and type 2 diabetes Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis Skeletal muscle fiber type: influence on contractile and metabolic properties Insulin induces a positive relationship between the rates of ATP and glycogen changes in isolated rat liver in presence of glucose; a 31P and 13C NMR study.Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents Insulin resistance in the offspring of parents with type 2 diabetes.Role of ROS and RNS Sources in Physiological and Pathological Conditions Insulin-Sensitizing Effects of Omega-3 Fatty Acids: Lost in Translation?Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR Reprogramming of energy metabolism as a driver of aging Skeletal Muscle Mitochondrial Bioenergetics and Morphology in High Fat Diet Induced Obesity and Insulin Resistance: Focus on Dietary Fat Source Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb Ischemia The Role of Organelle Stresses in Diabetes Mellitus and Obesity: Implication for Treatment Parkinson's disease, insulin resistance and novel agents of neuroprotection AMPK: a cellular metabolic and redox sensor. A minireview The complex interplay of genetic and lifestyle risk factors in type 2 diabetes: an overview Role of lipotoxicity in endothelial dysfunction Acylcarnitines: reflecting or inflicting insulin resistance?SIRT3 as a Regulator of Non-alcoholic Fatty Liver Disease Ectopic fat assessment focusing on cardiometabolic and renal risk Lipid composition of cell membranes and its relevance in type 2 diabetes mellitus Type 2 diabetes: etiology and reversibility Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress Role of mitochondria in nonalcoholic fatty liver disease Control of muscle mitochondria by insulin entails activation of Akt2-mtNOS pathway: implications for the metabolic syndrome Rosiglitazone-induced mitochondrial biogenesis in white adipose tissue is independent of peroxisome proliferator-activated receptor γ coactivator-1α

P2860

Q21135340-CC9AD4CC-2500-41EF-910A-AE33FA065E25 Q21195699-F6DC98D8-B2A5-470A-B469-596AFBDB5965 Q21285128-F8BD184C-65A6-4482-A7F1-85E3F4934B09 Q21563350-15038442-D06D-4DE2-9B50-A38F500EC764 Q24294870-CFA71413-AD20-43FD-876A-D73122FEC48B Q24300365-C275540C-ADE3-4855-A1F4-59536C0F3569 Q24532776-BA1BC28C-03B0-4946-9087-47657C0FD9EB Q24536351-FC892CD7-145C-439C-845F-18B3A2E30634 Q24561554-8534B226-256B-46BF-ABC6-CBF1CAFB99D2 Q24601095-A9BD71F8-BE1E-479D-913A-9215BC215A03 Q24632414-C3DFF6FD-E806-4143-9114-7382322FC18F Q24642546-3D1975BC-33E7-4276-A172-7F3E9D25B089 Q24650874-D7909776-4BBA-4E50-AC98-A921F763810A Q24652830-8E7A35EC-D27D-4AF0-8997-19A00BB17C28 Q24673585-A8FFBAB5-2980-4F26-AAD7-8A7264A2DD75 Q24798075-04340A00-E6FD-48A8-A233-76B5A7AE5118 Q24799445-3DAF2F1B-3686-4CAC-93F6-BF950D598BAF Q24812272-09DCBDCC-A263-4FA1-9B04-B34B72B99334 Q24812499-BE7C1951-71E9-4C0E-81FC-A1166F14F509 Q24816366-7DB99AB8-DFDC-4EF7-A8FE-1974D58AF99A Q26740342-2FEE0BC4-0F12-4641-AD6B-09533F0E019F Q26748802-7A10499A-D579-444D-AB23-5A2DAD994828 Q26749047-818FEB27-E175-42E2-BF55-36F04FB5F7C5 Q26766053-166EB293-CE14-4746-8C08-39A3A1A9775A Q26772781-E72BCF0C-8A56-4F65-8A54-A77A5DFEB5AF Q26774784-48E55E50-0EE4-49BF-B5C8-BE6015DC7BA5 Q26776377-D0BFC285-6BD4-4610-BCCB-AEC29DD00BF2 Q26853311-81975CAE-A7F3-4888-A5CB-02886870B54B Q26995682-D26D8911-5E77-4BDA-B903-74AB64C8318C Q26997813-2C0F0E42-3124-49F3-B5BE-6466BCE99CCE Q27000731-7768B4DE-65B9-458C-BE14-3945C8C148E8 Q27004603-57C0E298-985E-4482-A795-BFF5DF519D52 Q27009435-794A04D5-E400-4942-92EC-2D9DCAEA8673 Q27015940-AB19FC1B-F9C2-4B4F-B15B-A5093974F7E4 Q27016081-297B3C7E-D2F7-48BB-A4F9-9908374176B3 Q27016644-9C47C52D-FF36-4045-A5A3-040F022A5DDA Q27022552-6A43CFEF-0E06-4FA9-BCAB-281CF57EF5B6 Q27028142-7C063D76-C68B-4E18-8143-DC0F2B2554FD Q27301810-50B3EEFD-4AEA-47F8-8E66-7A9CBA7EA613 Q27314648-6ED06FE0-F529-44D4-9F22-CD80BD9FC421

P2860

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

http://www.wikidata.org/entity/Q29614548

description

2004 nî lūn-bûn

@nan

2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Impaired mitochondrial activit ...... patients with type 2 diabetes

@ast

Impaired mitochondrial activit ...... patients with type 2 diabetes

@en

type

label

Impaired mitochondrial activit ...... patients with type 2 diabetes

@ast

Impaired mitochondrial activit ...... patients with type 2 diabetes

@en

prefLabel

Impaired mitochondrial activit ...... patients with type 2 diabetes

@ast

Impaired mitochondrial activit ...... patients with type 2 diabetes

@en

P1433

Q29614548-DC55216E-5F42-471C-8DFF-61FAF64836FC

P1476

Q29614548-37DBEC7C-BC20-4942-A9BC-0313BBADC5A5

P2093

Q29614548-2BAA6635-E7F7-4AF0-8138-2ED90E76438B

Q29614548-3DD1F536-6686-4E28-9713-2AB27E7636A2

Q29614548-D4198178-9A62-4985-B1B0-10E412B5CDB4

Q29614548-DBDE866A-4A0E-47B4-AC38-B355054DF9B4

Q29614548-FDC226B4-C8FB-4ADB-A7AC-E6952DF98B15

P2860

Q29614548-066A7403-72DD-4182-A481-2E74DF858B4A

Q29614548-0CFB4B2E-ECA6-41D7-AFB0-77660DAA5798

Q29614548-113FE17B-9A6B-4FC0-8ABA-1192BBC58FB7

Q29614548-138E16CE-2CB3-47ED-A313-70F527721383

Q29614548-1622B8EB-8C75-4E5F-904C-0CD28D770E6E

Q29614548-16BB0512-EC51-40D1-885C-A0EF076CC2E8

Q29614548-17041CCF-45B3-4278-AD40-A01D1836ACB1

Q29614548-190894F2-9A0F-4FCF-BD22-FCFC97ED9975

Q29614548-1C2CF538-C425-4FB6-B5F1-0075D6FF5BF2

Q29614548-239B9E94-C31E-4D3F-B827-883616EECD3E

P304

Q29614548-DD4C143F-71C4-4EEC-8A5A-6BA408BFA00A

P31

Q29614548-4C297969-6965-4937-960B-AED306E00D8E

P3181

Q29614548-7B240EBA-3A3F-45AB-BC81-86AEDDAD265F

P356

Q29614548-036F78B8-AED4-4BD3-A246-F87E633DADF3

P407

Q29614548-365935E7-DA57-4AA5-9352-C7F9FCAC047A

P433

Q29614548-74C19838-E483-455D-8C8E-4C45005AEE67

P478

Q29614548-ACF750B3-1763-438E-9489-58554B001833

P5008

Q29614548-79CED77D-D3D8-4E8A-AB45-AA697B1622BF

P577

Q29614548-247733EF-6507-4F9A-A538-BBB69D3F42AD

P698

Q29614548-D3D122C8-394F-41F4-AC9F-3216915639A6

P921

Q29614548-4179754B-1729-45A8-A8F5-D332432DF914

Q29614548-519a3c96-48a2-398a-728f-c58442035bdd

Q29614548-53C8E564-3FF6-4A2D-97DE-548D0654E2D8

Q29614548-53aa9ef0-430d-1184-1846-2f8a829861fb

Q29614548-5DAAA133-A41B-4611-9262-9C2AC79DB242

Q29614548-c1c52dc7-41da-8307-fee9-18f7d1a08393

Q29614548-ca1520b7-4d75-a9d4-dd22-67ed03e7b3ed

P932

Q29614548-24196954-ED01-4200-B8A9-0F81A87D0D72

P3181

P356

P1433

The New England Journal of Medicine

P1476

Impaired mitochondrial activit ...... patients with type 2 diabetes

@en

P2093

Befroy D

http://www.w3.org/2001/XMLSchema#string

Dufour S

http://www.w3.org/2001/XMLSchema#string

Garcia R

http://www.w3.org/2001/XMLSchema#string

Petersen KF

http://www.w3.org/2001/XMLSchema#string

Shulman GI

http://www.w3.org/2001/XMLSchema#string

P2860

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

Mechanism of free fatty acid-induced insulin resistance in humans

Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1

Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus

Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle

Mechanisms of fatty acid-induced inhibition of glucose uptake

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

P304

664-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

551034

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA031314

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

350

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2004-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14960743

http://www.w3.org/2001/XMLSchema#string

P921

skeletal striated muscle

insulin resistance

oxidative phosphorylation

type-2 diabetes

P932

2995502

http://www.w3.org/2001/XMLSchema#string